U

Rafarma Pharmaceuticals, Inc. RAFA

$0.03 $0.00-3.03% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is a pharmaceutical-focused company that has historically been associated with the development, manufacturing, and commercialization of pharmaceutical products, with an emphasis on generic medicines and healthcare-related investments. Public disclosures indicate that the company has pursued opportunities tied to pharmaceutical production infrastructure and healthcare distribution, though the scope of active operations has varied over time based on available filings and market disclosures. Information regarding current large-scale commercial operations is limited in recent publicly accessible reporting.

The company’s historical positioning has been linked to pharmaceutical manufacturing assets and healthcare market participation in the Russian and broader Eurasian region. Available public records suggest that the company evolved through a combination of operating activities and investment-oriented corporate structuring tied to pharmaceutical production capabilities. Data regarding current revenue concentration, active product portfolios, and commercial scale is inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--

Balance Sheet

Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--

Cash Flow

Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--

Filings

Filing Date
Period Date
Next Filing
(est)

Price History

Loading...
52-Week Range32% of range
Low
$0.00
Current
$0.03
High
$0.09
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--

Dividends and Shares

Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Website
Phone Number
801-210-7135
Address
49 West 9000 South
Suite 1
Sandy, UT 84070
Country
Year Founded
--

Headlines

There are no news to display.